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A B S T R A C T
Detection of p53 antibody, a universal cancer biomarker, essential for the early diagnosis and prevention of
cancer mortality. Here, we report label free electrochemical detection of p53 antibody binding with DNA on a
graphene prepared by direct electrical exfoliation of pencil graphite in presence of aminoacid (glycine) in
aqueous solution for the first time. Role of glycine in preventing graphitization is analysed using Fourier
transform infrared spectroscopy, Raman, X-ray diffractommetry, X-ray photoelectron spectroscopy and trans-
mission electron microscopy. Graphene has been decorated with gold nanoparticles prior to the biofunctiona-
lization with DNA sequence, representing lung cancer, followed by its hybridization with a universal cancer
biomarker anti-p53 antibody. Changes in the cyclic volatmetric and impedance signal of the graphene‑gold
modified electrode upon the occurrence of molecular binding events is monitored in the presence of ferri/ferro
cyanide redox probe. The binding of DNA antibody has been theoretically confirmed using bioinformatic tool.
Selectivity of the sensor is demonstrated using anti p21 antibody and DNA sequences from E-Coli pathogen. The
cancer biomarker antibody can be detected in the concentration range from 0.1 ng/L to 0.1 μg/L. The minimal
concentration of dsDNA required for the efficient sensing of anti-p53 antibody is 0.6 fM. Both graphene pre-
paration and cancer biomarker sensing methods are simple, rapid, easy to fabricate, stable and can be utilized for
practical applications.
1. Introduction
Simple, fast and accurate diagnosis of early cancer, a second most
dangerous disease with increasing mortality rate worldwide (8.2 mil-
lion per year), is utmost important for the preventive care and ther-
apeutics. Human cancers (breast [1], liver [2], ovarian [3] and lung
[4]) are the result of malfunctioning of p53 antibody, a ‘guardian of the
gene’, that plays different activities like regulation of the cell cycle,
DNA repair, and programmed cell death [5,6]. Mutated p53 gene is
present in> 50% in all types of cancer cells, and identified by electro
chemiluminescence, calorimetric and immuno precipitation techniques.
The evolution of mutated gene increases the p53 antibody concentra-
tion in the cell and in the streaming blood and therefore, the direct
estimation of serum p53 antibody as the biomarker is highly preferable
over the DNA mutation screening. Binding of DNA with antibody is
important to control various cellular processes such as recombination,
replication, DNA repair and transcription. The dysfunction of this
process induces progression of various diseases [7]. Various methods
including electrophoretic mobility shift assays (EMSA) [8] or chemi-
luminescence assays [9], Fluorescence resonance energy transfer
(FRET) techniques [10], FRET–FLIM [11], circular dichroism [12],
atomic force microscopy [13], nuclear magnetic resonance [14], sur-
face plasmon resonance [15], etc. have been employed. These methods
require tedious experimental procedures and difficult to develop min-
iaturized portable system. These issues can be solved by employing
simple, cost effective and faster electrochemical sensing method.
Therefore, this work uses the double stranded DNA from lung cancer to
study its binding with p53 antibody by the electrochemical method.
Graphene, a 2D material with one atom thickness available abun-
dantly, can be used as a biosensing transducer owing to its high elec-
tronic conducting and easy biofunctionalization properties than the other
similar carbon nano materials. Biofunctionalization is done either
through non-covalent or by covalent attachment of biomolecule. In the
non-covalent method, DNA is attached on the graphene via π-π
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interaction. This method is used to pre-concentrate DNA and character-
ized using surface-enhanced laser desorption ionization time-of-flight
mass spectrometry (SELDI-TOF-MS) [16]. For the covalent functionali-
zation of graphene, the graphene surface is necessarily decorated or
modified using either metal or other molecules containing functional
groups [17,18]. Recently, p-aminophenol layer grafted with graphene
–gold nanoparticle film electrode was reported for immunosensing [19].
The method involves electro grafting of both p-aminophenol and GO
sequentially and decorated with gold nanoparticle for attaching the an-
tigen. Multilayered graphene with number of layers exceeding 17 attracts
high interest in the development of electronic devices along with other
metals for transistor constructions [20,21] recently for the fact that the
heterogeneous electron transfer rate of graphene increases regularly with
number of layers [22]. The multi layered structured graphene is used
energy storage, battery applications [23,24], loading of drugs, DNA,
antibody and stimulated release [25–28] photo degradation of organic
dye [29]. These multi layers are prepared by acid or amine functionali-
zation of the GO. The direct adsorption of DNA or antibody on the gra-
phene results in non-specific signal generation due to improper or-
ientation of DNA probes indicated by fluorescence quenching method
[30]. On the other hand, the label free (without using enzyme labels for
signal amplification) electrochemical sensing without DNA probe de-
gradation requires covalent linking of the capture probes. In this, a
multilayerd graphene has been prepared in presence of aminoacid (gly-
cine) by direct electrical exfoliation of pencil graphite in aqueous solu-
tion for the first time. Role of glycine in preventing graphitization is
analysed using Fourier transform infrared spectroscopy, Raman, X-ray
diffractommetry, X-ray photoelectron spectroscopy and transmission
electron microscopy. Graphene has been decorated with gold nano-
particles prior to the biofunctionalization with DNA sequence, re-
presenting lung cancer, followed by its hybridization with a universal
cancer biomarker anti-p53 antibody. Changes in the cyclic volatmetric
and impedance signal of the graphene‑gold modified electrode upon the
occurrence of molecular binding events is monitored in the presence of
ferri/ferro cyanide redox probe the dsDNA is assembled on the multi-
layered graphene –gold thin film via gold-thiol interactions. Sequentially,
the universal cancer biomarker p53 antibody is allowed to interact with
the complementary dsDNA form the dsDNA-p53 complex on the surface.
The anti-p21 antibody and dsDNA from E-coli were used to demonstrate
the selectivity of the sensor. The physicochemical and electrochemical
methods are employed for the characterization of multilayerd graphene
–gold composites and DNA-antibody interactions.
2. Experimental section
2.1. Materials and methods
Pencil graphite rod (0.7 mm diameter and 60mm length) was pur-
chased from a stationary shop. Potassium ferrocyanide, potassium fer-
ricyanide, sodium chloride, dimethyformamide (DMF), sodium dihy-
drogen phosphate and potassium chloride of analytical grade were
purchased from Himedia, India. Tetracholoroaurate, Anti-p53 and Anti-
p21 antibodies were purchased from Invitrogen, (adjoined with fisher
scientific recently). Milli-Q water (18.2MΩ) was used for all experi-
ments. 0.01M phosphate buffer of pH 7.4 containing NaCl (120mM),
NaH2PO4 (10mM) and KCl (2.7mM) was prepared and used for all
electrochemical experiments. 27-mer synthetic oligonucleotides re-
presenting the lung cancer DNA were synthesized by MWG biotech,
Ebersberg, Germany, with HPLC purification.
Capture probe (ssDNA): 5′-HS-(CH2)6-ATC ACA GAT TTT GGG CGG
GCC AAA CTG CTG-3′-II
Complementary target(dsDNA): 5′-CAG CAG TTT GGC CCG CCC
AAA ATC TGT GAT-3′-II
E-coli DNA sequences
Capture probe (ssDNA): 5′-HS-(CH2)6-CGA TCT GTT TTA TGT AGG
GTT AGG TCA-3′ -III
Complementary target (dsDNA): 5′-TGA CCT AAC CCT ACA TAA
AAC AGA TCG-3′ -IV
All DNA samples were prepared in SSC buffer (saline‑sodium citrate
buffer, pH 7.0). pH meter from Susima, AP-1PLVS, India, was used for
measuring the solution pH. A conventional three electrode cell con-
sisting of Ag/AgCl reference electrode, Pt wire counter electrode and
2mm diameter Au disk working electrode having 0.03 cm2 geometric
areas was used for all electrochemical measurements. The Au electrode
was initially treated with piranha solution for 30min, and rinsed
thoroughly with distilled water. The electrode was then polished using
Al2O3 powder (5.0, 1.0 and 0.05mM), and sonicated in Milli Q water.
CV and EIS were performed using a 6500D electrochemical analyzer
from CH Instruments, Texas, USA, in presence of 1mM [Fe(CN)6]3−/4-
in PBS buffer (pH 7.4). The CV was recorded in the potential window
−200 to +600mV at a scan rate 50mV s−1. The EIS measurements
were made by applying an ac potential amplitude± 5mV over the dc
potential 250mV (redox potential of 1mM [Fe(CN)6]3−/4- at gold
electrode in PBS) in the frequency range 100 kHz – 1 Hz. Impedance
data were plotted in the form of Nyquist plot. Zsimpwin software was
used to determine the charge transfer resistance (RCT). The EIS profile is
matched with Randles equivalent circuit [Rs (QCPERCT)W] with chi
square value 5.005×10−4. In this circuit, Rs is the background solu-
tion resistance, RCT the charge-transfer resistance, QCPE the electrical
double layer capacitance and W the Warburg coefficient.
PANalytical make Bruker D8-Advance powder diffractometer which
uses Cu-Kα1 radiation (2.2 kW max) was used for powder X-ray dif-
fraction measurements (PANalytical B.V., Lelyweg 1, 7602 EA ALMELO,
The Netherlands). Chemical Vapour Deposited gold (100 nm), Si and
graphite substrates were used for acquiring the FE-SEM images and EDS
spectra from Zeiss SEM instrument Hitachi (model Se3000H), Japan
which uses a LEO 1530 field emission. Images were recorded at an ac-
celerating voltage 10 kV with a secondary electron detector.
2.2. Simultaneous electrical exfoliation and reduction of pencil graphite by
glycine
Homemade variable DC power supply with Digital multimeter was
used for applying a constant DC potential +7 V between two pencil
electrodes in presence of 0.1M glycine. Thus obtained graphene was
washed with double distilled water, ethanol, acetone and filtration by
centrifuging at 8000 rpm for 5min. The final product was dried at 45 °C
for 2 h, Scheme 1 and named as g-G. The graphene product was con-
firmed by both electrochemical and physicochemical characterization
techniques (XRD, Raman, XPS, FTIR, TEM and FESEM).
2.3. Electrode modification
For modifying the gold electrode (AuE) surface with the above
synthesized g-G, 1.5mg of g-G was dispersed in 1mL DMF followed by
sonication for 15min. 2 μL of the mixture was drop casted on the AuE
and dried at an ambient temperature for 1 h. For the immobilization of
ssDNA on the g-G, the graphene modified AuE surface was further de-
corated with AuNP prepared by citrate reduction method [31]. 2 μL of
1 μM thiolated ssDNA probe was dropped onto the modified electrodes
and incubated for 1 h under humid conditions and washed with the
blank PBS buffer to remove the un-reacted ssDNAs [32]. 2 μL of 1 μM
target DNA (target II Section 2.1) was drop casted on the g-G-AuNP-
ssDNA modified electrode to hybridize with the ssDNA to form com-
plementary dsDNA for 1 h under identical experimental conditions. The
electrochemical studies were carried out by CV and EIS techniques in-
termittently in the PBS pH 7.4 in the presence of 1mM [Fe(CN)6]3−/4-.
Antibody interaction with the preformed dsDNA was made by in-
cubating the dsDNA modified surface with 2 μL of 0.1 μg/L anti-p53
antibody for 1 h under identical experimental conditions. Same pro-
tocol was followed for the negative control experiment using the E-coli
dsDNA and anti-p21 antibody in the selectivity experiments.
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2.4. Antibody preparation, DNA modelling and molecular docking of
selective DNA fragment and anti-p53 antibody
Three dimensional DNA model was generated using the DNA
Analysis and Rebuilding program (3D-DART) [33]. 3D-DART online
server modeled the DNA structure in canonical B-DNA conformation
with reference to the available DNA structures and the overhanging
base-pairs were converted to all-paired structures in accordance to
Watson–Crick counterparts. The crystal structure of Anti-p53 antibody
bound with Zinc metal was retrieved from Antibody Data Bank [PDB
ID: 2i00] [34]. Further, the antibody was optimized and minimized in
Schrodinger Antibody preparation wizard [35]. HDOCK server is a
hybrid docking algorithm, which implies a FFT-based global docking
protocol to sample the binding modes [36]. Antibody-DNA docking was
performed with default parameters to explore the binding properties of
the target DNA in the P53 antibody.
3. Results and discussion
3.1. Electrochemical characterization of glycine functionalized multi layer
graphene
Electrochemical properties of the graphite, graphene oxide (GO)
and g-G are examined by cyclic voltammetry in the presence of [Fe
(CN)6]3−/4- redox probe in PBS (pH 7.4), Fig. 1. Both the graphite and
g-G show higher peak currents (example ipa 9.71 and 11.7 μA ΔEp(peak-
to-peak separation) 110 and 90mV, respectively), compared to the GO
modified AuE that shows lower peak current (ipa: 4.4 μA) with increased
peak-to-peak separation ΔE (ΔEp: 160mV). Among the graphite and g-G
modified surfaces, higher reversible redox behavior was observed for
the g-G (Curve e, g., anodic peak current ipa 11.7 μA) with lower ΔEp
(90mV). This is related to the formation of thin layered graphene by
the in-situ exfoliation and reduction processes. In order to confirm the
presence of functional groups on the g-G, the g-G modified gold elec-
trode was potential cycled in the pure PBS solution and observed a
diffused reduction peak (at −1.0 V) (Fig. S1A). This reduction peak is
completely disappeared in the second cycle itself. This behavior is quite
similar to the electrochemical reduction of GO [37–39] indicating the
presence of few carboxyl functional groups on the g-G. After this ex-
periment, the g-G modified surface is reinvestigated for its charge
transport properties in the presence of [Fe(CN)6]3−/4- and observed no
signature of charge transport−, but exhibits a large charging current
than the unreduced g-G, Fig. S1B. This is again contradictory with the
observations made electrochemically for the reduced GO [37–39]
which exhibits higher charge transfer property than the unreduced GO.
Therefore, these behaviors indicate that when a strong reduction po-
tential was applied on the g-G modified surface, the intercalated glycine
may undergo self polymerization to form non-conducting film, pre-
venting the heterogeneous electron transfer from the [Fe(CN)6]3−/4-
(Fig.S1B). That is, glycine is attached on the graphene during the
electrical exfoliation of graphene. Because the GO surface stabilized
glycine reduces the charge transport, its reduction is prevented by ap-
plying the potential window between −200 to 700mV (Ag/AgCl) for
further studies. The role of glycine in the formation of graphene is
further examined by the physicochemical characterization of the g-G.
The XRD and Raman behaviors of the graphite, GO and g-G are
presented comparatively in Fig. 2. From the XRD pattern in Fig. 2A, it is
noted that the graphite exhibits peaks at 2θ 26.5° and 54.5° corre-
sponding to the (002) and (004) planes, respectively, while the g-G
showed only the (002) plane at 2θ 25.8° with broad and low intensity.
This is attributed to the random packing of graphene sheets which
arises from the reduced structural defects in the g-G [40,41]. In the
Raman spectroscopy, Fig. 2B, the graphite exhibits G-band (at
Scheme 1. Direct electrical exfoliation of pencil graphite in presence of glycine.
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Fig. 1. CV behaviors of unmodified (curve a), graphite (curve b), GO (cure c)
and g-G (curve d) modified Au electrode measured in presence of [Fe(CN)6]3−/
4- in PBS (pH 7.4) at a scan rate 50mVs−1.
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1562 cm−1) and a sharp 2D-band (at 2699 cm−1) corresponding to the
first order scattering of the E2g vibration mode and the second-order
two phonon mode, respectively. Moreover, a weak D-band, arising from
the disorder induced mode due to the presence of less structural defects,
is also observed for the graphite at 1342 cm−1. The intensity ratio of D
and G bands (ID/IG) is a measure of the presence of disorders and is
inversely proportional to the average size of the sp2 clusters [42]. For
the graphite, the observed ID/IG ratio was 0.07 nm. The D band for the
g-G located at 1344 cm−1 is resulted from the defect-induced breathing
mode of sp2 rings [43]. The G band at 1598 cm−1 for the g-G is due to
the first order scattering of the E2g phonon of sp2 carbon atoms. The
intensity of the D band is related to the size of the in-plane sp2 domains
[44] and its increased intensity indicates the formation of more sp2
domains. Higher ID/IG ratio for the g-G (0.6) than the graphite (0.07)
signatures the presence of higher amount of structural defects induced
by the introduction of oxygen functional groups during the simulta-
neous exfoliation and reduction processes in presence of glycine. This is
confirmed by the electro reduction of functional groups present in g-G,
Fig. S1A. Further, the increased I2D/IG ratio 0.4 obtained for the g-G
compared to the graphite (I2D/IG: 0.38) indicates the presence of defects
and the intercalated glycine in the g-G layer and prevention of gra-
phitization by the restacking of the exfoliated GO. Hence, the g-G
showed enhanced CV peak currents compared to the graphite in the
presence of [Fe(CN)6]3−/4-.
Coordination of glycine with the g-G is further confirmed from the
FTIR (Fig. S2) and XPS (Fig. 3A and B) spectral behaviors. Intensities of
FTIR bands in the frequency region 1000 to 1800 cm−1 are decreased
effectively for both the graphite and g-G compared to the unreduced GO
which consists of alkoxy CeO stretching vibrations (1086 cm−1), aro-
matic C=C (1620 cm−1) stretching and OeH stretching (3450 cm−1).
The presence of weak intense peaks at 1330 and 1550 cm−1 in the FTIR
spectra of g-G indicate the CeN and CeH bending arising from the
intercalated glycine [45]. Similarly, the C1s spectrum of g-G (Fig. 3B)
showed higher intensity C]C band (284.5 eV), lower intensity C]O
band (288.4 eV) with a new CeN band at 285.4 eV compared to the
unreduced GO (Fig. 3A), indicating the restoration of pi-electron
network due to the reductive interaction nature of the glycine [45] with
the g-G, Scheme 1.
The TEM (Fig. 3C and D) and HRSEM (Fig. S3) show flake like
structure for the GO, whereas a thin layered film structure for the g-G,
Fig. 3. The interlayer distance 0.38 nm obtained from the TEM along
with XRD peak broadening and higher I2D/IG (0.4) [40] again confirms
the presence of glycine in the thin layer g-G.
3.2. DNA functionalized g-G for label free selective sensing of anti-p53
antibody
For the orientation controlled immobilization of DNA on the g-G,
the AuNPs were used to decorate the g-G by electrostatic interaction
[46]. Following this, the thiolated single stranded DNA (HS-ssDNA) was
immobilized through gold–thiol chemistry on the g-G-AuNP. Fig. 4A
shows that the immobilizations of HS–ssDNA on the g-G-AuNP lowered
the peak currents (Table S1, 7.37 μA) and increased ΔEp (200mV, peak-
to-peak separation) and RCT values (Fig. 4B and Table S2,
1.713×104 Ω cm−2) compared to the g-G-AuNP modified electrode
(10.6 μA, 100mV and 8.08× 103Ω cm−2). This is due to the electro
static repulsion between the negatively charged immobilized ssDNA
and [Fe(CN)6]3−/4-. Further, hybridization with the complimentary
ssDNA (target II) to form a perfect double stranded DNA (dsDNA) in-
creased further the RCT (4.999×104 Ω cm−2), ΔEp (230mV) and de-
creases the peak current (5.35 μA) compared to the ssDNA surface, at-
tributed to the increased negative charges and molecular layer
thickness. These observations are in agreement with the previous lit-
erature reports [17,18]. In contrast, hybridization with the complete
non-complementary target DNA showed insignificant change in the CV
and EIS profiles compared to the ssDNA immobilized surface. These
data indicate the efficient discrimination of the complementary and
non-complementary hybridization by the multi layered g-G–AuNP
composite film sensor. The complementary dsDNA formed surface is
utilized further for the anti-p53 antibody binding.
P53 is a universal cancer biomarker and p53 antibody interaction
with DNA is reported for the early diagnosis of cancer using immono
c: g-G
b: GOIn
te
ns
ity
 / 
a.
u.
2  / degree
a: Graphite
A
0
300
600
Graphite2D
G
In
te
ns
ity
 (a
.u
)
Raman Shift (cm-1)
2DD
B
0
800
1600
2400
G
In
te
ns
ity
 (a
.u
)
Raman Shift (cm-1)
D
GOC
20 40 60 80 500 1000 1500 2000 2500 3000 3500
500 1000 1500 2000 2500 3000 3500
500 1000 1500 2000 2500 3000 3500
0
300
600
2600 2800 3000
2640 2700
A
2D gyrGO
2D
G
In
te
ns
ity
 (a
.u
)
Raman Shift (cm-1)
D
D g-G
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sensing principle [47]. Two different electrodes having dsDNA with
identical electrochemical behaviors were prepared. On each surface,
both the tumor suppressor anti-p53 and non tumor suppressor anti p21
(control antibody) antibodies were allowed to interact for 1 h and wa-
shed with blank PBS to remove the unreacted antibodies on the surface.
CV and EIS behaviors of these surfaces are depicted in Fig. 5A&B,
Scheme 2.
The interaction of target anti-p53 antibody results in decreased CV
peak currents (Table S3, ipa: from 5.35 μA to 3.53 μA), increased ΔEp
(from 230mV to 240mV) and RCT (Fig. S4A and Table S4, 4.99×104
to 9.88×104 Ω cm−2). The interaction of control anti-p21 antibody
shows insignificant change in the CV and EIS profiles (Table S3, from
5.35 μA to 5.36 μA). Interaction of either anti-p53 and anti p21 anti-
bodies with the ssDNA modified showed insignificant change in the
electronic signal indicating no complex of DNA-antibody complex for-
mation. A similar experiment made by the interactions of anti-p53 and
anti-p21 antibodies with the pathogenic E-Coli complementary dsDNA
modified electrode exhibits negligible changes in the CV (Fig. 5B,
Scheme 2) and EIS profiles (Fig. S4B). Hence, the anti-p53 antibody
selectively binds only with the lung cancer complementary dsDNA and
not with the E-Coli complementary DNA. This confirms the fact that the
sensor can discriminate the cancer and pathogenic affected samples. To
validate this binding of lung cancer dsDNA with the p53 antibody, an
in-silico experiment has been conducted using bioinformatic tools.
Further the DNA-antibody interaction has been studied by compu-
tational Rebuilding program (3D-DART) [33]. 3D single stranded
structure of target lung cancer DNA (30 bases) was modeled in 3D-
DART tool. The Anti-p53 antibody complexed with Zinc metal was re-
trieved from Antibody Data Bank (PDB) is prepared in Schrodinger suite
to assign proper bond orders, lengths and addition of hydrogen atoms.
Refined antibody structure was used as the semi-flexible input for
docking analysis. Since the study is intended to find the binding
properties of target DNA, HDOCK server automatically predicts the
favorable binding sites in the antibody and docks the target DNA pro-
vided in 3D conformation onto the predicted binding site. The docking
protocol of HDOCK scanned the favorable regions of anti-p53 receptor
and bound the modeled DNA by docking algorithm. The anti- p53 an-
tibody - DNA complex shown the HDOCK score of −537.96, high
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negative values indicates the higher binding affinity of the target DNA
with the anti-p53 antibody (Fig. 6). The antibody - DNA complex is
stabilized by the two hydrogen bonds (Lys1232……Cyt18 and Ly-
s1136……Ade19) and supported by aromatic interaction
(His1165……Thy27). Apart from these three interactions, several po-
sitive contacts were observed between the surface of receptor and le-
gend DNA molecule. Lys1232 and Lys1136 residue has formed hy-
drogen bonds with Adenine18 and 19 at the distance of 2.56 and 2.68
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Fig. 5. Selective anti-p53 antibody detec-
tions using (A) Lung Cancer and (B) pa-
thogenic E-coli DNA modified g-G-AuNP
electrodes. CV recorded in phosphate buffer
(pH 7.4) in presence of 1 mM [Fe(CN)6]3−/
4. Curve a: g-G- AuNP-DNA. Curve b:
a+ anti-p53. Curve c: a+ anti-p21. (C)
Variation of charge transfer resistance RCT
with target antibody concentration mea-
sured using electrochemical impedance
spectroscopy.
Scheme 2. Selective label free DNA-anti-p53 antibody sensing at g-G-AuNP sensor surface by electrochemical method.
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respectively. Similarly the aromatic bond was observed between the
His1165 residue and Thymine27 at a distance of 2.37. Based on the
interaction, it is evident that the lung cancer DNA is interacting to anti-
p53 antibody with high affinity and the structural level interactions
observed were confirming the experimental results. This experiment
proves the highly selective sequence specific interaction nature of the
sensor in detecting the p53 cancer biomarker. The concentration studies
were made on g-G-AuNP-dsDNA modified electrode and the linear
range obtained was 0.1 ng/L to 0.1 μg/L (Fig. 5C). The observed lowest
detection limit of p53 antibody biomarker is almost comparable with
the literature report (0.1pgmL−1= 0.1 ng/L) on the graphene-AuNP
composite using immunochemistry [19]. However, we have not used
the self assembled monolayer for anchoring GO and its subsequent re-
duction by electrochemical method.
Reproducibility data presented in Fig. S5 are for the four repeated
measurements obtained using four different DNA-anti p53 modified
surfaces prepared under similar experimental conditions. The closeness
of the data reveals the high reproducibility nature of the sensor de-
veloped. The stability of G-G-AuNP-dsDNA and G-G-AuNP-dsDNA-anti
p53 antibody layers are modified on two different AuEs are validated
for the stability for on six days and presented in Fig. 7. The electrodes
show very small and negligible change in the anodic peak currents for
all surfaces examined, indicating the excellent ultra sensitivity, se-
lectivity, stability, and reproducibility of sensor in both the studies of
DNA and DNA-anti p53 antibody binding. The lowest concentration of
dsDNA required for the efficient signal generation using this newly
prepared graphene-AuNP composite has been evaluated by the studying
the concentration of dsDNA formation on the surface and signal gen-
eration in presence of anti p53 antibody. It is noted that the con-
centration of 0.6 fM of dsDNA is enough to observe the change in the
electrochemical signal.
4. Conclusion
Direct electrical exfoliation of graphene in presence of glycine re-
sults in the formation of few layered graphene indicated by the ap-
pearance of high intense G and D bands with the I2D/IG ratio 0.4. The
FTIR and XPS data indicates the presence of CN bonding from the
glycine in the graphene. This may be due to the interaction of amphi-
phile glycine by the electrostatic interaction with the oxy functional
groups, supported by the observation of poor charge transfer in the
presence of [Fe(CN)6]3−/4- due to the formation of poly glycine.
Detection of selective label free binding of lung cancer dsDNA with anti
p53 antibody biomarker was achieved by electrochemical method on
the graphene‑gold nanoparticle composite thin film in the concentra-
tion range 0.1 ng/L–0.1 μg/L. This platform could be easily prepared
and implemented in different applications.
Fig. 6. Interaction insights of DNA in Anti-p53 antibody. The hydrogen bonds formed between Lys1232……Cyt18 and Lys1136……Ade19 were represented by red
dotted lines. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
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Fig. 7. Study of stability of g-G-AuNP-dsDNA (A) and g-G-AuNP-dsDNA-p53 (B) modified electrodes monitored voltammetrically in presence of 1 mM [Fe(CN)6]3−/4-
in phosphate buffer.
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